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Securinrested at metaphase of the second meiotic division (metII) for an indeterminate
time before fertilization. During this period, which can last several hours, the continued attachment of sister
chromatids is thought to be achieved by inhibition of the protease separase. Separase is known to be
inhibited by binding either securin or Maturation (M-Phase)-Promoting Factor, a heterodimer of CDK1/cyclin
B1. However, the relative contribution of securin and CDK/cyclin B1 to sister chromatid attachment during
metII arrest has not been assessed. Although there are conditions in which either CDK1/cyclinB1 activity or
securin can prevent sister chromatid disjunction, principally by overexpression of non-degradable cyclin B1
or securin, we ﬁnd here that separase activity is primarily regulated by securin and not CDK1/cyclin B1. Thus
the CDK1 inhibitor roscovitine and an antibody we designed to block the interaction of CDK1/cyclin B1 with
separase, both failed to induce sister disjunction. In contrast, securin morpholino knockdown speciﬁcally
induced loss of sister attachment, that could be restored by securin cRNA rescue. During metII arrest separase
appears primarily regulated by securin binding, not CDK1/cyclin B1.
© 2008 Elsevier Inc. All rights reserved.IntroductionMammalian eggs are ovulated following arrest at metaphase of the
second meiotic division (metII), but only become fertilized several
hours later (Jones, 2005). Therefore, the egg has the difﬁcult task of
maintaining proper bi-orientation and pairing of its sister chromatids
over a period of many hours until gamete fusion. Any precocious loss
of sister chromatid cohesion would potentially lead to aneuploid
embryos, in the sameway that precocious sister disjunction in mitosis
leads to aneuploid daughter cells (Kops et al., 2005; Musacchio and
Salmon, 2007).
In mitosis, sister chromatid cohesion is broken by the protease
separase (Wirth et al., 2006), whose catalytic activity is inhibited by two
mutually exclusivemechanisms. Firstly, through binding to securin (Ciosk
et al., 1998; Lee and Orr-Weaver, 2001; Petronczki et al., 2003; Zou et al.,
1999), whose degradation at anaphase-onset is triggered by the E3 ligase
the Anaphase-Promoting Complex/Cyclosome (APC) (Peters, 2006). APCs, University Drive, University
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ones).
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l rights reserved.activityalso induces loss of the regulatorycyclinB1 subunit ofMaturation-
Promoting Factor (MPF; CDK1/cyclin B1) (Doree and Hunt, 2002; Jones,
2004). Secondly, separase is inhibited by binding to CDK1/cyclin B1 (Gorr
et al., 2005; Holland and Taylor, 2006; Stemmann et al., 2001), however
there is a mutual exclusivity at the molecular level with respect to the
inhibitory partner because separase cannot bind simultaneously both
securin and CDK1/cyclin B1 (Gorr et al., 2005). Separase is likely to be
responsible for both homologue disjunction during the ﬁrst meiotic
division and sister chromatid disjunction during the second meiotic
division. In meiosis I separase involvement has been shown directly
because deletion of its catalytic domain during oocyte growth prevents
fully grown oocytes from undergoing homologue disjunction (Kudo et al.,
2006). Separase is also likely involved in meiosis II, because expression of
non-degradable securin in metII eggs which are then activated, blocks
sister chromatid segregation (Madgwick et al., 2004). Furthermore
knockdown of Sgo2, which protects centromeric cohesion from separase
action, leads to separation of sisters (Lee et al., 2008).
The present study set out to examine what controls separase
during metII arrest of mouse oocytes during in vitro culture. During
the ﬁrst meiotic division separase activity is most likely regulated by
securin rather than by CDK1/cyclin B1, because blocking the normal
decline in securin, which can readily be observed in meiosis I (Reis et
al., 2007), using a non-degradable securin inhibits homologue
disjunction (Herbert et al., 2003); whereas preventing separase
interaction with CDK1/cyclin B1 does not (Gorr et al., 2006). In metII
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degradable (Δ90) cyclin B1 or non-degradable securin has the ability
to maintain sister chromatin attachment following sperm fusion
(Madgwick et al., 2004). These observations, although important in
implicating separase in sister chromatid disjunction, fail to give any
context to the importance of CDK1/cyclin B1 and securin in the
inhibition of separase when levels are not raised. Indeed, the relative
contribution of MPF and securin to separase inhibition during an
unperturbed mitotic division is still much debated (Chang et al., 2003;
Hagting et al., 2002) but in some circumstances such as postmigratory
germ cells inhibition of separase appears wholly dependent on just
one mechanism (Huang et al., 2008).
Here, we use CDK1 pharmacological inhibition as well as antibody
inhibition of CDK1/cyclin B1 binding to separase, to demonstrate that
CDK1/cyclin B1 activity does not regulate separase during metII arrest.
Instead through antisense knockdown studies we conclude that it is
securin that regulates separase activity during metII arrest.
Materials and methods
All chemicals were obtained from Sigma-Aldrich (UK), unless
otherwise stated, and of tissue culture or embryo-tested grade where
appropriate.
Gamete collection and culture
Four to six week old MF1 mice (Harlan, UK) were used. GV oocytes
and metII eggs were collected from hormonally primed animals, as
previously described (Madgwick et al., 2006; Madgwick et al., 2004).
For bench handling, microinjections and imaging experiments,
Germinal Vesicle (GV) and metII eggs were cultured in M2 media.
For longer term incubation, the oocytes were cultured in MEM (Gibco,
UK) supplemented with 20% of foetal bovine serum in a 5% CO2
humidiﬁed incubator at 37 °C. Tomaintain GV arrest the culture media
was supplemented with 1 μM milrinone (Reis et al., 2006).
Parthenogenetic activation of metII eggs was achieved by washing
eggs into Ca2+-free M2 media containing 10 mM SrCl2 (Bos-Mikich et
al., 1997). In some experiments 50 μM roscovitine (Calbiochem, UK)
was added to the culture media. Here a coverslip rather than mineral
oil was used to preventmedia evaporation. Roscovitine could partition
into the oil and hence onewould not know the actual concentration in
the culture medium. Also, this partitioning could reduce the
concentration of roscovitine in the medium below that required to
inhibit CDK1.
Microinjection and imaging
All microinjections were made on the heated stage of a Nikon
TE300 inverted microscope, as described previously (Jones and Nixon,
2000). In brief, fabricated micropipettes were inserted into cells using
the negative capacitance overcompensation facility on an electro-
physiological ampliﬁer (World Precision Instruments, UK); while cells
were immobilised with a holding pipette. This procedure ensured a
high rate of cell survival (N90%) and a low rate of parthenogenetic
activation. A precise injection volume (0.3–1% of the total egg volume)
was achieved by using a Pneumatic PicoPump. cRNAs were injected at
a pipette concentration of 1 μg/μl, and morpholinos at 1.5 mM.
Brightﬁeld and Hoechst images were recorded by epi-ﬂuorescence
and a Princeton Instruments Interline MicroMax CCD camera.
Metamorph and Metaﬂuor imaging software (Universal Imaging
Corp.) was used for image capture and analysis.
Morpholinos and cRNA
An antisensemorpholino oligonucleotidewas designed to span the
immediate 5′UTR next to the start codon of securin (securinMO),GATAAGAGTAGCCATTCTGGATTAC (GeneTools, OR). As a control, 5
base pair mismatches (underlined) were introduced into a second
morpholino (5MM-securinMO) GATAACACTACCGATTCTCGATTAC. Both
morpholino oligonucleotides were used at a micropipette concentra-
tion of 1.5 mM and microinjected as previously described (Reis et al.,
2006).
Cyclin B1, Δ90 cyclin B1 and securin cRNA were synthesised from
constructs we made previously (Chang et al., 2004; Hyslop et al.,
2004; Reis et al., 2007) using a modiﬁed pRN3 vector designed to
produce untagged protein or C-terminally coupled to Yellow Fluor-
escent Protein (YFP). cRNA was synthesised using T3 mMESSAGE
mMACHINE (Ambion), and dissolved in nuclease-free water to a
concentration of approximately 1 μg/μl before microinjection.
Antibodies
An anti-CBD antibody was generated against the cyclin-binding
domain of separase as described previously (Gorr et al., 2006). The
antibody was raised against the two known CDK1-binding determi-
nants of mouse separase (amino acids 1120–1134 and 1340–1354). A
further IgG-control antibodywas also used. Both antibodies were used
at a micropipette concentration of 1 μg/μ1.
Western blotting
Oocytes were washed in phosphate-buffered saline (PBS) with 1%
polyvinylpyrrolidone (PVP) solution and then heated at 95°C for 5 min
with 5×sample buffer (0.06 M Tris/HCl at pH 6.8, 2% SDS, 10% glycerol,
0.025% bromophenol blue and 5% 2-mercaptoethanol). Proteins were
fractionated at 200 mV for 50 min on an X Cell II™ blot Module
(Invitrogen, UK) using a 10% NuPage Bis–Tris pre-cast gel (Invitrogen)
and MOPS running buffer. Proteins were transfered to polyvinylidene
ﬂuoride membranes (PVDF) for 1.5 h at 100 mV. Anti-securin (ab3305,
1:1000, AbCam, UK), anti-cyclin B1 (ab72,1:400, AbCam, UK) and anti-
beta actin (ab3280,1:400, AbCam, UK)were used forWestern blotting.
Standard enhanced chemiluminescence (ECL) techniques (Amer-
sham Biosciences, UK) were used for detection according to
manufacturer's instructions.
Chromosome analysis
Chromosome spreads were performed by the air-drying technique
of Tarkowski (Tarkowski, 1966) and C-spreads were prepared as
described previously (Chandley, 1987). Brieﬂy for C-banding, oocytes
were ﬁrst ﬁxed on slides and then incubated at room temperature with
0.2 M HCl for 1 h, then 4% barium hydroxide at 37 °C for 30 s. A
subsequent incubation in 2× standard saline citrate (0.3 M sodium
chloride/0.03 M trisodium citrate) at 60 °C for 1 h was followed by
Giemsa staining for 15 min. Slides were rinsed in distilled water
following each step.
Results
Wewanted to establish the relative contribution of CDK1/cyclin B1
and securin to separase inhibition in eggs during their metII arrest. In
initial experiments Yellow Fluorescent Protein (YFP) tagged cRNA
constructs for cyclin B1 (n=32) and securin (n=25) were injected into
oocytes and expression monitored during maturation, from GV to
metII arrest. Ultimately we wanted to establish if both proteins
showed equal stability during the period of metII arrest, and the
visible tagging allowed us to do this in real-time from the time of ﬁrst
polar body (PB1) extrusion onwards.
Cyclin B1 and securin degradation were readily observed during
meiosis I and reached a minimum at the time of PB1 extrusion
(representative traces in Figs. 1A, B). Such degradation has been
described previously (Herbert et al., 2003; Ledan et al., 2001; Madgwick
Fig. 1. Exogenous cyclin B1 and securin synthesis rates during meiotic maturation.
Cyclin B1-YFP (A) or securin-YFP (B) were microinjected into GV oocytes, which were
then matured in culture. YFP ﬂuorescence readings were recorded at the times shown
during oocyte maturation and following extrusion of the ﬁrst polar body (PB1).
Brightﬁeld images were also captured at the same times to determine when PB1
extrusion occurred (arrow). (C) Comparison of cyclin B1-YFP and securin-YFP
ﬂuorescence levels in eggs two hours after PB1 extrusion. There was no statistical
difference between ﬂuorescence levels (t-test). To allow comparison between eggs of
YFP ﬂuorescence levels after PB1, ﬂuorescence at time t (Ft) were all normalised with
respect to the minimum ﬂuorescence obtained, which invariably corresponded towhen
the PB1 was extruded (Fmin, plotted as a dashed horizontal line). YFP ﬂuorescence was
plotted as Ft/Fmin×100.
Fig. 2. Endogenous cyclin B1 and securin expression varies after polar body extrusion.
(A)Western blot of oocytes (n=20 per lane) for cyclin B1 and securin during GV arrest, at
the times indicated in hours during maturation relative to milrinone wash out,
immediately following PB1 extrusion or during metII arrest at 14 h. (B) Densitometric
analysis of Western blots (n=3) performed as in panel A (mean±sem). Cyclin B1 levels
rise appreciably following PB1 extrusion, however there is little change in securin. (C)
Western blot of eggs for securin (n=40) with or without incubation in Sr2+ containing
medium for 3 h. In panels A and C actin was used as a loading control.
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within 30min after PB1 extrusion (Madgwick et al., 2006), therefore we
calculated the mean rate of cyclin B1 (n=32) and securin (n=25) re-
expression during a 2 h period after PB1 (Fig. 1C). The cyclin B1 and
securin ﬂuorescence rises following entry into meiosis II were
indistinguishable, suggesting similar stability, and such observations
would be consistent with their APCcdc20 mediated degradation being
inhibited by Emi2 expression at this time (Liu and Maller, 2005;
Madgwick et al., 2006; Rauh et al., 2005; Shoji et al., 2006; Tung et al.,
2005).The YFP protein constructs used, showed equal stability of cyclin
B1 and securin during metII arrest. Findings that would be consistent
with either one having a role as a separase inhibitor. The constructs
are certainly able to act as real-time readouts for APCcdc20 activity but
importantly they may not reﬂect changes in endogenous protein
during either maturation or metII arrest. For example endogenous
protein expression could be affected by changes in mRNA poly(A) tail
length, a process very active in oocytes and known to regulate cyclin
B1 expression (Ledan et al., 2001; Mendez and Richter, 2001; Tay et al.,
2000); but which may not inﬂuence expression of exogenously added
cRNA. Therefore, to examine changes in endogenous cyclin B1 and
securin we Western blotted oocytes (n=20 per lane) at various times
during maturation and following arrest at metII (Fig. 2A). Although
both proteins were degraded during meiosis I similar to their YFP-
labelled constructs, very marked differences in re-stabilisation of
endogenous cyclin B1 and securin were observed following PB1
extrusion. Cyclin B1 levels rapidly rose following PB1 extrusion, and
went on to reach equivalent levels of expression to those observed at
peak times during oocyte maturation (Figs. 2A, B, n=3 independent
blots). In contrast, securin levels did not increase appreciably, and
instead remained at levels near those at PB1 extrusion.
Securin was not absent frommetII eggs; a prominent securin band
was observed when we doubled the number of eggs per lane (Fig. 2C,
n=40). Also loss of this endogenous securin was observed when eggs
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Ca2+ release induced by sperm (Bos-Mikich et al., 1997) (Fig. 2C). Such
observation is consistent with loss of ﬂuorescent protein tagged
securin expressed in fertilized metII eggs reported previously (Chang
et al., 2004), and the ability of Sr2+ to induce loss in Emi2 (Madgwick et
al., 2006).
MPF as an inhibitor of separase at metII?
The lack of appreciable securin resynthesis after PB1 extrusion
suggested that either lower levels of securin than are evident in
meiosis I are sufﬁcient to inhibit separase during metII arrest or,
alternatively, that separase inhibition is achieved either wholly or in
part by binding CDK1/cyclin B1. To begin to distinguish theseFig. 3. CDK1 inhibition does not induce sister chromatid separation. (A) Rates of PB2 extrusio
or addition of roscovitine (Rosc.); assessed at 7 h. (B) Timing of PB2 extrusion following add
extruding a PB2. Some eggs were slower in extruding a PB2 following roscovitine addition th
indicated. Note that anaphase appears normal with chromatin visible in both the PB2 and the
of roscovitine at the times indicated. Note the abnormal events associated with roscovitine ad
stretched between the egg and PB2 (E, arrow) and an egg in which all the chromatin enters
attached sister chromatids (n=25). Scale bars 20 μm (D–F); 10 μm (G).possibilities we incubated mouse eggs with the CDK1 inhibitor
roscovitine (Bain et al., 2007; Meijer et al., 1997) to examine for
effects on egg activation and speciﬁcally sister chromatid disjunction.
This pharmacological inhibitor was chosen because of its reported
ability to induce extrusion of the second polar body (PB2) at the dose
used in these following experiments (Phillips et al., 2002).
In agreement with previous studies, addition of roscovitine to
mouse eggs induced PB2 extrusion, albeit at lower levels than Sr2+
containing medium (Fig. 3A), and in some eggs over a longer
timeframe (Fig. 3B). For both Sr2+ and roscovitine activated eggs we
labelled chromatin with Hoechst dye and monitored the fate of sister
chromatids in real time with the morphological events of PB2
extrusion. Sr2+-medium induced sister disjunction, with anaphase
readily observed, and half the chromatin mass segregating into then in metII eggs, following no additions (no add.), incubation in Sr2+ containing medium,
ition of roscovitine or Sr2+, plotted as a cumulative percent of the total number of eggs
an Sr2+. (C) Brightﬁeld and Hoechst images of eggs following Sr2+ addition at the times
egg (arrow). (D–F) Brightﬁeld (D–F) and Hoechst (E, F) images of eggs following addition
dition: a transitory extrusion of a polar body (D); a cut phenotype inwhich chromatin is
the polar body (F, circle). (G) Chromosome spread of a roscovitine treated egg showing
383I. Nabti et al. / Developmental Biology 321 (2008) 379–386polar body (Fig. 3C, arrow). In contrast we observed a number of
defects of PB2 extrusion with roscovitine, and importantly in all cases
never observed a normal metaphase–anaphase transition. In many of
the roscovitine-treated eggs PB2 extrusion was transitory or aborted,
with PB2 resorption immediately following any extrusion (Fig. 3D).
Therefore, it is likely that roscovitine is able to induce higher rates of
PB2 extrusion than that reported in Fig. 3A but is missed because that
extrusion is transitory, or only in part, rather than permanent. A
similar phenomenon of polar body resorption has been observed in
mouse oocytes during meiosis I when they are expressing non-
destructible securin (Herbert et al., 2003). We speculate that transient
polar bodies may be due to a failure in all of these oocytes to form a
central spindle structure necessary for proper abscission (Mollinari et
al., 2005).
In addition to transitory polar bodies, we also observed chromo-
some segregation defects in those eggs in which the PB2 was not
resorbed. In some there was a stretching of chromatin between the
egg and the PB2 (Fig. 3E, arrow), reminiscent of the ‘cut’ (cell
untimely torn) phenotype, which results when activated eggs
express non-degradable securin (Madgwick et al., 2004). We also
observed eggs in which all the chromatin mis-segregated into the
PB2 (Fig. 3F, circle). Taken together, all these observations suggest
that inhibition of MPF cannot induce separation of sister chromatids
although it can induce cytokinesis after metII arrest. To conﬁrm the
Hoechst real-time observations, we performed chromosome spreads
on eggs treated with roscovitine. As expected, sister chromatids
remained attached in 25 out of 25 analyzed, roscovitine-treated eggs
(Fig. 3G).Fig. 4. Inhibition of separase–CDK1 binding fails to induce sister chromatid separation. (A) Ass
of chromatin on a metII plate (arrow). The antibody had little effect on chromatin. (B) Chrom
attached sister chromatids (one chromatid is magniﬁed in inset). (C, D) Chromosome spread
with either control IgG (C, n=7) or anti-CBD antibody (D, n=8) and incubated for 3 h. IgG i
antibody caused separation of homologues. (Insets show a magniﬁed bivalent or dyad). ScaThe above data suggest that MPF activity does not regulate
separase activity during metII arrest or is at least not crucial for
preventing premature onset of anaphase. We decided to use an
alternative approach to conﬁrm this, namely, by inhibiting the
interaction of CDK1/cyclin B1 with separase more speciﬁcally.
Previously, we generated an anti-CBD antibody that was able to
block the interaction of CDK1/cyclin B1 with separase (Gorr et al.,
2006). Injection of this antibody into metII eggs would be predicted,
therefore, to induce sister chromatid separation, if separase were
regulated by CDK1 activity. However, we found that ∼90% of eggs
remained metII arrested following injection of the anti-CBD antibody,
as assessed by Hoechst staining (Fig. 4A, n=21, arrow). To conﬁrm
directly that sisters were still attached in anti-CBD injected eggs, we
performed spreads on six anti-CBD injected eggs and observed again
no evidence of sister chromatid disjunction (Fig. 4B).
It remained possible that the anti-CBD antibody was only effective
at inhibiting the interaction of CDK1/cyclin B1 with separase prior to
their mutual binding, and that the binding of CDK/cyclin B1 and
separase was so tight that the antibody would not be effective at
dissolving the complex once formed. To test this directly, we inhibited
homologue disjunction in mouse oocytes during meiosis I by injecting
cRNA for non-degradable cyclin B1 (Δ90-cyclin B1) into GV oocytes,
which were then matured in culture. Such oocytes remained arrested
at metI with paired homologues (bivalents), as reported previously
(Herbert et al., 2003). This arrest was due to CDK1 dependent
inhibition of separase activity, because injection of the anti-CBD
antibody but not of control IgG triggered homologue disjunction as
judged by chromosome spreads (Figs. 4C, D). Interestingly, we did notessment of metII status in eggs injectedwith anti-CBD antibody, as judged by alignment
osome spread of an anti-CBD antibody injected egg (n=6) at 3 h after injection showing
of an oocyte arrested at metI by injection of Δ90-cyclin B1 which is then further injected
njection had no effect on homologues, which remain attached; however the anti-CBD
le bar 20 μm (A), or 10 μm (B–D).
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this to the continued MPF activity, which is unaffected (or even
increased) by the antibody (Gorr et al., 2006) (see Discussion).
Importantly, these experiments performed on metI-arrested oocytes
exemplify the ability of the anti-CBD antibody to dissolve pre-formed
complex of CDK1/cyclin B1 and separase in vivo.
Securin as an inhibitor of separase during metII arrest?
All the above data suggest that CDK1/cyclin B1 is not responsible
for inhibiting separase activity during metII arrest. Therefore, we used
an antisense morpholino oligonucleotide against securin (securinMO)
to knockdown securin expression in oocytes. SecurinMO very
dramatically knocked down securin in GV arrested oocytes after
24 h (Fig. 5A). In contrast, a control 5 base mis-match securin
morpholino (5MM-securinMO) had no effect.
GV oocytes that were knocked down for securin by this protocol, as
well as control 5MM-securinMO injected oocytes, were then matured
in culture and analyzed for their retained abilities to extrude a PB1 and
to align chromatin on a metII spindle. There was no difference in the
ability of either group of oocytes to extrude a PB1 (Fig. 5B), however,
the chromatin conﬁguration following Hoechst staining was com-
pletely different. In the control morpholino injected oocytes, the
chromatin readily aligned on a metaphase plate (Figs. 5B and C,
arrow). In contrast, chromatin was dispersed throughout the
cytoplasm in the vast majority of securinMO injected oocytes.
We thought the above would be consistent with a lack of sister
chromatin pairing following PB1 extrusion. Therefore, we performed
chromosome spreads on both sets of oocytes. In the control morpholino
injected oocytes, normal numbers of dyads (attached sisters) were
observed as judged by either Hoechst staining (Fig. 5D, n=13) or
visualization of centromeric DNA by C-banding (inset). In contrast, allFig. 5. Securin knockdown induces separation of sister chromatids. (A) Western blot for se
securinMO or 5MM-securinMO as indicated (n=3). SecurinMO but not its 5 base mismatch co
Percentage PB1 extrusion rates in oocytes injected with either securinMO or 5MM-securinMO
were stained with Hoechst and categorised as having an intact metII spindle (solid bar) or ch
and Hoechst image in an egg that had been injected with the morpholinos indicated and m
5MM-securinMO injected oocytes, while chromatin is dispersed in the oocytes injected with
oocytes at either 7 h (E) or 14 h (D, F and G) followingmicroinjection of either 5MM-securinM
immediately before maturation was induced. Scale bar 20 μm (C) and 10 μm (D–G).spreads performed on securinMO injected oocytes showed that although
homologues and sister chromatids were attached before PB1 extrusion
(Fig. 5E,n=14), themajority of sister chromatidswere separated after PB1
(Fig. 5F, n=9), with separation conﬁrmed by further C-banding (inset).
It was important to exclude that the action of the securin
morpholino was really due to an off-target effect. Assuming its
speciﬁcity, it should be possible to rescue the phenotype by injection
of securin-encoding cRNA into GV oocytes just prior to induction of
oocyte maturation by removal of milrinone. This rescue is made
possible by the securinMO being designed to the 5′UTR that is lacking
in the exogenous cRNA. Importantly, in all eggs in which successful
spreads were performed, the introduction of securin cRNA rescued a
normal dyad spread in securinMO injected oocytes (Fig. 5G, n=12),
with further C-banding conﬁrming that homologues had undergone
disjunction but that sister chromatids were still attached (inset). Thus,
replenishing securin in securinMO injected oocytes is sufﬁcient to
restore normal progression throughmeiosis I and subsequent arrest at
metII with paired sisters.
Securin knockdown during metII arrest
By examination of chromosomes in oocytes yet to extrude a PB1 we
found no evidence that the securin knockdown generated premature
separation of either homologues or sister chromatids (Fig. 5E). However,
in oocytes that had extruded a PB1 the vast majority of sisters were
separated (Fig. 5F), suggesting that the lack of securin had led to a loss of
sister chromatid attachment concomitant with homologue disjunction.
We could not determine precisely if sister disjunction was indeed
simultaneous with that of homologue disjunction because of technical
limitations: the time lag between being able to identify homologue
disjunction and processing the oocytes ready for chromosome spreads
was estimated to be at least 30 min.curin in GV arrested oocytes, n=0–50 per lane, cultured for 24 h following injection of
ntrol morpholino caused a large knockdown in securin expression (estimated 80%). (B)
as in panel A following milrinone wash-out, assessed at 14 h. All eggs extruding a PB1
romatin that was dispersed in the cytoplasm (open bar). (C) An example of a brightﬁeld
atured as in panel B. The arrow shows a normal metII plate which was prevalent in the
securinMO. (D–G) Chromosome spreads and associated C-banding (D, F, and G, inset) in
O (D) or securinMO (E–G). In panel G securin cRNAwas further microinjected into oocytes
385I. Nabti et al. / Developmental Biology 321 (2008) 379–386We resolved the problem of determining if securin alone was
responsible for maintaining sister attachment during metII arrest by
using the securinMO to knockdown securin expression in eggs already
arrested at metII. We argued that such knockdown during metII arrest
should be possible, given that the APC is not completely inhibited by
Emi2 during metaphase II arrest (Nixon et al., 2002); indeed securin-
induced loss bymorpholino knockdownwas recently reported inmouse
eggs (Marangos and Carroll, 2008). Freshly ovulated metII eggs were
collected at 12 h post-hCG, microinjected with either 5MM-securinMO
(n=14) or securinMO (n=14) and examined 12 h later for attachment of
sister chromatids. Although this timeperiod is greater than the window
in which physiologically fertilization normally happens, we ﬁnd that
most eggs in culture maintain their arrest during this period. Indeed, in
86% of the 5MM-securinMO injected eggs there was no evidence of any
sister chromatid disjunction (Fig. 6A), with chromosome spreads
showing the normal complement of 20 attached sister chromatids (Fig.
6B). In contrast 71% of the securinMO injected eggs showed a mixture of
attached and separated sisters, with complete disjunction evident in
some eggs (Figs. 6A, C). We conclude that securin is required for
continued attachment of sister chromatids during metII arrest.Fig. 6. Securin morpholino induced sister chromatid separation in metII eggs. (A)
Percentage of eggs having separated (black bars) or attached (white bars) sister
chromatids followingmicroinjection of either 5MM-securinMO or securinMO and culture
for 12 h. (B) Chromosome spread of a 5MM-securinMO injected egg, demonstrating
attached sisters. (C) Chromosome spread of a securinMO injected egg in which all of the
sister chromatids had undergone disjunction. Scale bar 10 μm (B, C).Discussion
This study set out to examine the relative contribution of securin and
CDK1/cyclin B1 to inhibit separase activity during the period of metII
arrest in mouse eggs. We already know, by overexpression in eggs of
non-degradable constructs for either cyclin B1 or securin, that either
mechanism has the capacity to prevent sister chromatid separation
(Madgwick et al., 2004). However, their relative contribution to separase
inhibition in an unperturbed physiological context remained an
important unresolved issue. Endogenous securin re-accumulated at a
much lower rate than cyclin B1 duringmetII arrest, in contrast to similar
rates of expression for exogenous constructs, suggesting that this lower
level of securin is to do with dissimilar rates of expression rather than
degradation. Preventing the interaction of CDK1/cyclin B1with separase
failed to induce sister chromatid separation: either pharmacologically
using the CDK1 inhibitor roscovitine or directly by injection of an anti-
CBD antibody, which had the ability to dissolve the interaction of
separasewith CDK1. In contrast, securin knockdown in GV oocytes using
antisense oligonucletidemorpholino led to sister chromatid disjunction,
and its speciﬁcity was proven by rescue of a normal phenotype with
securin cRNA. Furthermore the securin morpholino also led to sister
chromatid dis-junctionwhen injected intometII eggs. Therefore, despite
the fact that both pathways have the capacity to inhibit separase and that
lower securin levels are observed inmeiosis II thanmeiosis I, it is securin
rather than CDK1 that constitutes the anaphase inhibitor in female
meiosis II.
Inhibition of CDK1 induces cytokinesis but not sister separation
Roscovitine addition to mouse eggs at the dose used here, has
already been shown to induce PB2 extrusion (Phillips et al., 2002).
Although the decrease in MPF activity was clearly inducing cytokin-
esis, we failed to observe disjunction of sisters. To the contrary, we
observed a variety of defects all associated with a lack of sister
disjunction: sometimes all of the chromatin remained in the egg or
was moved into the polar body. In other instances, chromatin bridges
persisted between the polar body and the egg. This pinching of
apparently unsegregated chromatin by the ingressing cleavage furrow
is reminiscent of the ‘cut’ phenotype, which can readily be induced by
expression of non-degradable securin (Hagting et al., 2002; Zur and
Brandeis, 2001). Inhibition of CDK1 by roscovitine implies that in
mouse eggs the drop in CDK1 activity at fertilization would be
necessary to induce cytokinesis but not anaphase. This is supported by
more general studies in mitotic cells, where CDK1 activity appears
necessary and sufﬁcient to prevent cytokinesis (Potapova et al., 2006;
Vassilev et al., 2006).
Would inhibiting CDK1 activity by a pharmacological inhibitor
necessarily free separase from CDK1/cyclin B1? We have no direct in
vitro evidence to demonstrate this, however, our metI data are
compelling; when roscovitine is added to metI oocytes that have been
injected with the anti-CBD antibody it induces homologue disjunction
(Gorr et al., 2006). Therefore, in a process, inwhich separase is inhibited
by CDK1 activity, addition of roscovitine can induce anaphase. These
data would ﬁt a mechanism in which the interaction of separase with
CDK1/cyclin B1 is dynamic, with continual assembly and disassembly of
the complex. We showed this is the case by the ability of the anti-CBD
antibody to induce homologue disjunction in oocytes held at metI by
constitutively active CDK1 (Fig. 4D). Because separase dephosphoryla-
tion can readily beobservedduringpassage throughmitosis (Stemmann
et al., 2001) and CDK1-mediated phosphorylation is required prior to
CDK1 binding, it makes mechanistic sense that roscovitine should be
able to reverse the association of CDK1 with separase — at least in the
presence of cellular phophatases. In any event, we corroborated the lack
of efﬁcacy for CDK1 in inhibiting separase during metII arrest by
injecting the anti-CBD antibody. This measure had no effect on metII
arrested eggs, with chromosome spreads showing attached sisters. In
386 I. Nabti et al. / Developmental Biology 321 (2008) 379–386contrast, when the same experiment was performed on metI arrested
oocytes, in which metaphase arrest was caused by CDK1 dependent
inhibition of separase, the antibody induced homologue disjunction. In
these oocytes it was interesting how the lack of a PB1 showed that
cytokinesis had not occurred, and this is surmised to be due to the
maintenance of MPF activity.
Securin inhibits separase activity in meiosis II
A securin antisense morpholino injected either into GV oocytes,
which were then allowed to mature, or into metII arrested eggs,
blocked the ability of eggs to maintain attachment of sisters. This
effect appeared speciﬁc since it was not observed with a 5-base mis-
match morpholino and could be rescued, when tested in GV oocytes,
by addition of securin cRNA immediately prior to oocyte maturation.
Therefore, we conclude that securin is needed in order to maintain
sister chromatid cohesion in metII.
Data here show that securin loss induced by morpholino in GV
oocytes does not lead to premature separation of homologues during
meiosis I (Fig. 5E). This would at ﬁrst appear to suggest a securin-
independent mechanism of separase control in meiosis I but in fact is
more likely due to residual securin levels following knockdown being
able to inhibit separase (Fig. 5A). Indeed securin may be maintained at
a high level in GV oocytes in order prevent excessive cyclin B1 loss
during prophase arrest (Marangos and Carroll, 2008), by being able to
offer itself up for degradation to APCcdh1, which is active at this time
(Reis et al., 2006), in preference to cyclin B1.
The physiological role of securin in both GV arrest (Marangos and
Carroll, 2008) and prevention of sister chromatid disjunction during
metII arrest would both help to explain the reduced fertility of the
securin knockout mouse, in which litter sizes are less than half that of
heterozygotes (Wang et al., 2001).
In summary, the experiments reported herein demonstrate that
securin rather than CDK1/cyclin B1 appears to be responsible for
inhibiting separase activity during metII arrest, despite both having
the capacity to do so when their levels are elevated. In further studies
it will be interesting to examine if the maintenance of securin levels in
meiosis II present problems for eggs in keeping cohesion during post-
ovulatory ageing.
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